WO1991004270A1 - Proteines modifiees a conservation des semences - Google Patents
Proteines modifiees a conservation des semences Download PDFInfo
- Publication number
- WO1991004270A1 WO1991004270A1 PCT/AU1990/000430 AU9000430W WO9104270A1 WO 1991004270 A1 WO1991004270 A1 WO 1991004270A1 AU 9000430 W AU9000430 W AU 9000430W WO 9104270 A1 WO9104270 A1 WO 9104270A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protein
- phaseolin
- plant
- dna
- storage protein
- Prior art date
Links
- 108010016634 Seed Storage Proteins Proteins 0.000 title claims description 16
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 70
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 55
- 230000031787 nutrient reservoir activity Effects 0.000 claims abstract description 25
- 230000004048 modification Effects 0.000 claims abstract description 16
- 238000012986 modification Methods 0.000 claims abstract description 16
- 230000009261 transgenic effect Effects 0.000 claims abstract description 9
- 230000000717 retained effect Effects 0.000 claims abstract description 3
- LWTDZKXXJRRKDG-KXBFYZLASA-N (-)-phaseollin Chemical compound C1OC2=CC(O)=CC=C2[C@H]2[C@@H]1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-KXBFYZLASA-N 0.000 claims description 100
- 101710163504 Phaseolin Proteins 0.000 claims description 50
- LWTDZKXXJRRKDG-UHFFFAOYSA-N phaseollin Natural products C1OC2=CC(O)=CC=C2C2C1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-UHFFFAOYSA-N 0.000 claims description 48
- 108020004414 DNA Proteins 0.000 claims description 30
- 150000001413 amino acids Chemical group 0.000 claims description 26
- 230000035772 mutation Effects 0.000 claims description 15
- 238000003780 insertion Methods 0.000 claims description 13
- 230000037431 insertion Effects 0.000 claims description 13
- 102000053602 DNA Human genes 0.000 claims description 10
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 10
- 235000021374 legumes Nutrition 0.000 claims description 10
- 229930182817 methionine Natural products 0.000 claims description 10
- 101710196023 Vicilin Proteins 0.000 claims description 7
- 238000001727 in vivo Methods 0.000 claims description 7
- 230000004988 N-glycosylation Effects 0.000 claims description 5
- 230000013595 glycosylation Effects 0.000 claims description 5
- 238000006206 glycosylation reaction Methods 0.000 claims description 5
- 101710094902 Legumin Proteins 0.000 claims description 4
- 238000012217 deletion Methods 0.000 claims description 4
- 230000037430 deletion Effects 0.000 claims description 4
- 241000589155 Agrobacterium tumefaciens Species 0.000 claims description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 3
- 241000700605 Viruses Species 0.000 claims description 3
- NEKNNCABDXGBEN-UHFFFAOYSA-L disodium;4-(4-chloro-2-methylphenoxy)butanoate;4-(2,4-dichlorophenoxy)butanoate Chemical compound [Na+].[Na+].CC1=CC(Cl)=CC=C1OCCCC([O-])=O.[O-]C(=O)CCCOC1=CC=C(Cl)C=C1Cl NEKNNCABDXGBEN-UHFFFAOYSA-L 0.000 claims description 3
- 239000013604 expression vector Substances 0.000 claims description 3
- 239000013612 plasmid Substances 0.000 claims description 3
- 238000006467 substitution reaction Methods 0.000 claims description 3
- 125000000539 amino acid group Chemical group 0.000 claims description 2
- 244000005700 microbiome Species 0.000 claims description 2
- 230000004543 DNA replication Effects 0.000 claims 3
- 210000000349 chromosome Anatomy 0.000 claims 1
- -1 cosmids Substances 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 239000013598 vector Substances 0.000 abstract description 6
- 235000018102 proteins Nutrition 0.000 description 46
- 239000013638 trimer Substances 0.000 description 36
- 108090000765 processed proteins & peptides Proteins 0.000 description 29
- 229920001184 polypeptide Polymers 0.000 description 27
- 102000004196 processed proteins & peptides Human genes 0.000 description 27
- 241000196324 Embryophyta Species 0.000 description 25
- 235000001014 amino acid Nutrition 0.000 description 23
- 229940024606 amino acid Drugs 0.000 description 23
- 238000000034 method Methods 0.000 description 18
- 239000012634 fragment Substances 0.000 description 12
- 235000006109 methionine Nutrition 0.000 description 11
- 244000046052 Phaseolus vulgaris Species 0.000 description 9
- 240000004713 Pisum sativum Species 0.000 description 9
- 235000010582 Pisum sativum Nutrition 0.000 description 8
- 210000004899 c-terminal region Anatomy 0.000 description 8
- 239000013078 crystal Substances 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- 108091034117 Oligonucleotide Proteins 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 235000016709 nutrition Nutrition 0.000 description 7
- 244000068988 Glycine max Species 0.000 description 6
- 235000010469 Glycine max Nutrition 0.000 description 6
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 6
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 6
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 6
- 125000003275 alpha amino acid group Chemical group 0.000 description 6
- 230000027455 binding Effects 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 230000003993 interaction Effects 0.000 description 6
- 238000002703 mutagenesis Methods 0.000 description 6
- 231100000350 mutagenesis Toxicity 0.000 description 6
- 229960000187 tissue plasminogen activator Drugs 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000012856 packing Methods 0.000 description 5
- 238000012163 sequencing technique Methods 0.000 description 5
- 235000010520 Canavalia ensiformis Nutrition 0.000 description 4
- 244000045232 Canavalia ensiformis Species 0.000 description 4
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 4
- 244000061176 Nicotiana tabacum Species 0.000 description 4
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 4
- 108010022233 Plasminogen Activator Inhibitor 1 Proteins 0.000 description 4
- 102100039418 Plasminogen activator inhibitor 1 Human genes 0.000 description 4
- 210000000234 capsid Anatomy 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- 108090000565 Capsid Proteins Proteins 0.000 description 3
- 108700020911 DNA-Binding Proteins Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 108020004682 Single-Stranded DNA Proteins 0.000 description 3
- 238000002441 X-ray diffraction Methods 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 238000004590 computer program Methods 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 238000002741 site-directed mutagenesis Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 125000000134 2-(methylsulfanyl)ethyl group Chemical group [H]C([H])([H])SC([H])([H])C([H])([H])[*] 0.000 description 2
- 241000020089 Atacta Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 244000105627 Cajanus indicus Species 0.000 description 2
- 235000010773 Cajanus indicus Nutrition 0.000 description 2
- 102100023321 Ceruloplasmin Human genes 0.000 description 2
- DWAKXSZUASEUHH-RXMQYKEDSA-N Cucurbitine Chemical compound OC(=O)[C@@]1(N)CCNC1 DWAKXSZUASEUHH-RXMQYKEDSA-N 0.000 description 2
- 108060006006 Cytochrome-c peroxidase Proteins 0.000 description 2
- 230000004568 DNA-binding Effects 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 239000005864 Sulphur Substances 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 240000004922 Vigna radiata Species 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- DWAKXSZUASEUHH-UHFFFAOYSA-N cucurbitine Natural products OC(=O)C1(N)CCNC1 DWAKXSZUASEUHH-UHFFFAOYSA-N 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000001493 electron microscopy Methods 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 230000035784 germination Effects 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 150000002742 methionines Chemical class 0.000 description 2
- 102000035118 modified proteins Human genes 0.000 description 2
- 108091005573 modified proteins Proteins 0.000 description 2
- 235000002949 phytic acid Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000002864 sequence alignment Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- BQMDWLHBHLILMV-HVTWWXFQSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-4-methylsulfanylbutanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-methylsulfanylbutanoic acid Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(O)=O BQMDWLHBHLILMV-HVTWWXFQSA-N 0.000 description 1
- 102100025643 60S ribosomal protein L12 Human genes 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- GNKVBRYFXYWXAB-WDSKDSINSA-N Asn-Glu-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O GNKVBRYFXYWXAB-WDSKDSINSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 108700020473 Cyclic AMP Receptor Proteins 0.000 description 1
- 101710096438 DNA-binding protein Proteins 0.000 description 1
- 101710195723 DNA-binding protein HU Proteins 0.000 description 1
- 241000702463 Geminiviridae Species 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- IRJWAYCXIYUHQE-WHFBIAKZSA-N Gly-Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CN IRJWAYCXIYUHQE-WHFBIAKZSA-N 0.000 description 1
- 108700037728 Glycine max beta-conglycinin Proteins 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- YQFZRHYZLARWDY-IHRRRGAJSA-N Leu-Val-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN YQFZRHYZLARWDY-IHRRRGAJSA-N 0.000 description 1
- NFLFJGGKOHYZJF-BJDJZHNGSA-N Lys-Ala-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN NFLFJGGKOHYZJF-BJDJZHNGSA-N 0.000 description 1
- WQWZXKWOEVSGQM-DCAQKATOSA-N Lys-Ala-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN WQWZXKWOEVSGQM-DCAQKATOSA-N 0.000 description 1
- WGILOYIKJVQUPT-DCAQKATOSA-N Lys-Pro-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O WGILOYIKJVQUPT-DCAQKATOSA-N 0.000 description 1
- XGIQKEAKUSPCBU-SRVKXCTJSA-N Met-Met-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCSC)N XGIQKEAKUSPCBU-SRVKXCTJSA-N 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- 102000008300 Mutant Proteins Human genes 0.000 description 1
- 108010021466 Mutant Proteins Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108010084695 Pea Proteins Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 235000016816 Pisum sativum subsp sativum Nutrition 0.000 description 1
- 108700001094 Plant Genes Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- SSJMZMUVNKEENT-IMJSIDKUSA-N Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CO SSJMZMUVNKEENT-IMJSIDKUSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 102000018594 Tumour necrosis factor Human genes 0.000 description 1
- 108050007852 Tumour necrosis factor Proteins 0.000 description 1
- FTKXYXACXYOHND-XUXIUFHCSA-N Val-Ile-Leu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O FTKXYXACXYOHND-XUXIUFHCSA-N 0.000 description 1
- DFQZDQPLWBSFEJ-LSJOCFKGSA-N Val-Val-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)O)N DFQZDQPLWBSFEJ-LSJOCFKGSA-N 0.000 description 1
- 241000219977 Vigna Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 235000010726 Vigna sinensis Nutrition 0.000 description 1
- 244000042314 Vigna unguiculata Species 0.000 description 1
- 235000010722 Vigna unguiculata Nutrition 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000037429 base substitution Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000002983 circular dichroism Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000037029 cross reaction Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 235000005489 dwarf bean Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 108010083391 glycinin Proteins 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 108010082286 glycyl-seryl-alanine Proteins 0.000 description 1
- 238000009998 heat setting Methods 0.000 description 1
- 230000009569 heterotrophic growth Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000004923 pancreatic tissue Anatomy 0.000 description 1
- 235000019702 pea protein Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 238000003976 plant breeding Methods 0.000 description 1
- 210000002729 polyribosome Anatomy 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 210000004767 rumen Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000003019 stabilising effect Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 108010036387 trimethionine Proteins 0.000 description 1
- 230000001810 trypsinlike Effects 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8251—Amino acid content, e.g. synthetic storage proteins, altering amino acid biosynthesis
- C12N15/8253—Methionine or cysteine
Definitions
- This invention relates to plant seed storage proteins, and in particular to methods of modifying said proteins at specific sites.
- WO/8903887 discloses a process for production of a mammalian peptide via expression of a modified seed storage protein gene in a transgenic plant.
- the most commonly used vector is Agrobacterium tumefaciens Ti plasmid, which is successful in transferring genetic
- seed storage proteins Most of the protein found in mature seeds belongs to a class called the seed storage proteins. This term is used to describe those proteins whose function is to provide, upon germination, a source of fixed carbon and nitrogen to sustain the early heterotrophic growth of the seedling. However, it is because of the importance of seeds to human nourishment that so much work has been directed at understanding seed proteins.
- seed proteins are those from the agriculturally important legumes, soya bean (Glycine max) , garden pea (Pisum sativum) and French bean (Phaseolus vulgaris), although increasing attention is being given to food crops of the Third World, including cow pea (Vigna unguiculata), mung bean (V. radiata) and pigeon pea (Cajanus cajan).
- legume storage proteins which are mostly of the salt-soluble globulin class, are a
- vicilins 15 has been found to occur twice in vicilins 16 , suggesting a repeated structural motif in vicilins.
- arcelin Another seed storage protein, arcelin, has been identified in certain wild forms of Phaseolus vulgaris (Romero A. et al (1986) Theor. Appl. Genet 72.123-128; Osborn et al. (1986) Theor. Appl. Genet. 71 847-855); these proteins are toxic to bruchid pests of beans, and transfer of the cloned arcelin gene to other bean plant confers insect resistance (European Patent Application No. 337750: The Plant Cell
- phaseolin the major 7S storage protein from the French Bean Phaseolus vulgaris.
- Specific protein engineering targets in this system include improved nutritional value, altered stability with respect to functionality in food systems, and general use as a high-level expression system.
- Phaseolin a vicilin-like molecule
- Phaseolin trimer M r about 150 000
- the phaseolin trimer associates into a dodecamer 18 below pH 4.5.
- phaseolin is a
- tPA tissue plasminogen activator
- PAI-1 plasminogen activator inhibitor-1
- polypeptides of the trimeric seed storage protein phaseolin comprise two amino acids
- structurally-similar units each made up of a ⁇ -barrel and an ⁇ -helical domain.
- the ⁇ -barrel has the "jelly-roll" folding topology shown by viral coat proteins and the ⁇ -helical domain shows structural similarity to the helix-turn-helix motif found in certain DNA-binding proteins.
- the tetramer of trimers referred to above turns out to be the form of the molecule in the crystals studied here.
- the major barrier to modifying plants to produce seed storage proteins with commercially desirable properties is knowledge of the three-dimensional structure of the storage proteins.
- phaseolin structure of a representative seed storage protein, phaseolin.
- thermostability for heat-setting properties in snack foods (c) thermostability for heat-setting properties in snack foods.
- the present invention provides a mutein which is a variant of a naturally-occurring legume seed storage protein, wherein said mutein has a modified primary structure relative to said legume storage protein, but retains the tertiary and quaternary structure of said legume storage protein.
- tertiary and quaternary structure For the purposes of this specification, retention of the tertiary and quaternary structure is to be understood to mean that elements of that tertiary and quaternary structure which are not the subject of primary structure modifications are substantially unaffected by said modifications.
- a plant 7S or 11S storage protein modified at a specific amino acid residue or a specific region of its amino acid sequence, wherein the tertiary and quarternary structure of the naturally occurring storage protein is retained.
- the modification is selected from the group consisting of:
- a DNA molecule whose sequence encodes a mutein, as defined above.
- this DNA encodes a protein having the properties of a plant 7S or 11S storage protein, and also encodes one or more of the modifications set out above.
- Plasmids, expression vectors, and microorganisms comprising said DNA are also within the scope of the invention.
- transgenic plant or part thereof having a DNA sequence as definee above.
- the plant part is a seed.
- the modified DNA thus represents the initial embodiment of the changes; such DNA will be converted, via the processes of transcription and translation in the cell, to yield the modified seed storage protein.
- Figure 1 (25 sheets) represents the atomic co-ordinates of phaseolin in orthogonal ⁇ units.
- phaseolin trimer is coincident with the Y axis of the co-ordinate frame.
- the coordinates of the C atoms have been deposited by the applicant in the
- Figure 2 represents schematic diagrams showing the two observed patterns of interaction between the ⁇ + ⁇
- Figure 3 represents a stereo pair showing a C ⁇ trace of the phaseolin trimer, viewed down the molecular three-fold towards the centre of the tetramer.
- the N- and C-termini of each subunit are labelled.
- the two possible ways of linking the two ⁇ + ⁇ units to form the subunit are
- Figure 4 is a diagram showing the structure of native phaseolin (A) and the proposed high-methionine mutant phaseolin (B) in the neighbourhood of residues 84 to 88. The methionine sidechains of the mutant are seen to be
- residues in the same ⁇ -sheet as residues 84 to 88 are not shown.
- Figure 5 is a diagram showing the structure of native phaseolin (A) and the proposed high-methionine mutant phaseolin (B) in the neighbourhood of residues 261-265.
- the methionine sidechains of the mutant are seen to be
- residues in the same ⁇ -sheet as residues 261-265 are not shown.
- the secondary structure assignments are based on the current unrefined model and thus that the precise start and end points of the strands and helices may be in error by one or two amino acids in some places.
- the 411 residue protein has a five amino-acid insertion after residue 189 and a nine amino-acid insertion after residue 390.
- the 412 residue protein has a further insertion of one amino acid after residue 100.
- the chain trace of the electron density map (not shown) is that of the 397 amino-acid protein (termed the ⁇ -type polypeptide 11 ) and shows no break or weakening of electron density in the vicinity of residue 189.
- the map shows weak evidence of glycan binding at both known Asn-X-Ser/Thr glycosylation triplets 24 .
- the density is not yet sufficiently clear to provide information about the nature of heterogeneity of the glycans.
- Figure 2 shows a schematic drawing of the polypeptide. It consists of two structurally-similar units of about 160 amino acids each. These are related by a
- Each unit is itself an ⁇ + ⁇ two-domain structure, the first of some 110 residues being a classic viral capsid jelly-roll structure, and the second smaller domain being a cluster of three helices, including a
- a fourth helix in the N-terminal unit which is not structurally associated with the three-helix cluster, forms part of the connection through to the C-terminal unit.
- the helical domains comprise residues ca 156-181 and 340-371, each being a three-helix cluster. These helices bear a
- the internal sequence repeat 16 observed in phaseolin, jack bean canavalin and pea vicilin is the basis for the structural repeat described here.
- the sequence similarity in the internal repeat is low ( ⁇ 15% identity), but the amino-acid alignment corresponds to the structural repeat perfectly in many places and to within a few residues in the worst cases.
- the domains are remarkably similar; a least-squares fit of the C ⁇ positions in corresponding structural elements of the pair of units yields an r.m.s. deviation of only 2.2 ⁇ .
- the six structural ⁇ + ⁇ units which comprise the phaseolin trimer are arranged alternately up and down around the
- trimer is
- the jelly-roll ⁇ -barrel has a remarkable capacity to exist in different states of oligomerization 32,33 .
- the B-I-D-G face of the two barrels associate with each around the pseudo-diad in what appears to be a typical example of aligned packing of ⁇ -sheets.
- the two potential N-linked glycosylation sites are both within the C-terminal barrel on strands A and I respectively. The sugar attached to strand I could contact the neighbouring N-terminal barrel.
- the helical domains of the subunits are closely associated with each other around the pseudo-diad relating the neighbouring subunits (see Figure 2b). As mentioned above, the
- helix-turn-helix motifs formed by helices 2 and 3 of each domain are similar to those found in certain DNA-binding proteins 35 , typified by the Cro protein.
- phaseolin to the helix-turn-helix motif formed by residues 16-36 of Cro yields an r.m.s. deviation of 1.9 ⁇ and 1.3 ⁇ respectively, within the spread determined for these motifs 35 .
- the capacity of helix-turn-helix structures to bind DNA is associated with their condensation into dimers with diad symmetry coincident with that of double-stranded DNA, in particular with elements of the diad-related helices positioned 34 ⁇ apart and binding to consecutive major grooves of DNA. No such 34 ⁇ period is evident in the dimerisation of the phaseolin helical domains, nor indeed are the two domains identical.
- phaseolin the second helix in the motif (i.e. the third in the helical domain) is exposed to the environment in both structural units on the polypeptide and within the trimer
- phaseolin polypeptide translocation of the phaseolin polypeptide from its site of synthesis on membrane-bound polysomes through the endoplasmic reticulum into storage bodies 41,3 makes such an interaction unlikely. Nevertheless, DNA-binding studies could provide direct evidence for or against a role for storage proteins in the regulation of their own high level of synthesis.
- the inter-trimer contact in the tetramer occurs at the tetrahedral diad axes. It consists of a symmetry-related pair of interactions, each involving the N-terminal ⁇ -barrel of one subunit with the C-terminal ⁇ -barrel of a subunit from the neighbouring trimer.
- the N-terminal strands of polypeptides from neighbouring trimers are also in contact at the tetrahedral diad.
- Sequence alignments imply structural similarity of 7S proteins from common bean, jack bean, soybean and pea seeds 12,15,16. Insertions and deletions in these alignments are, with minor modifications, compatible with the phaseolin structure (see Table 1). For the most part, the phaseolin sequence is shorter than the other sequences, the exception being a five residue insertion around position 350, which may affect the structure of the connection between helices 1 and 2 of the C-terminal structural unit.
- a preliminary structure for jack bean canavalin shows pseudo 32 point group symmetry and a viral capsid domain in each of the two structural units per polypeptide.
- legumin protein cucurbitin has point group symmetry 23, at least at low resolution (ca 20 ⁇ ) .
- oligomeric form is believed to proceed via a 7S (trimer) intermediate, the final coalescing of trimers not occurring until cleavage of the polypeptides into the basic and acidic chains 44 . If the trimer form is indeed similar to the vicilin 7S molecules, with pseudo point group 32, then a rearrangement of the subunits within the trimer must accompany the formation of the 11S particle, in order to satisfy the resulting cubic arrangement of diads and triads.
- phaseolin Transgenic tobacco plants containing normal or modified phaseolin genes were then monitored for the production and deposition of phaseolin. Whereas in both cases phaseolin expression was achieved, deposition of the modified protein in the storage bodies did not occur, suggesting prior
- site directed mutagenesis is used to introduce desired mutations at defined sites in known fragments of wild type phaseolin cDNA.
- Mutations are introduced by known methods, such as those described by Kunkel (46), into restriction fragments which include the segment of DNA encoding the locus for the desired mutation.
- the resulting DNA is used to transfect a host, such as E.coli, and single stranded DNA prepared from plaques.
- the presence of the desired mutation is confirmed by complete sequencing of the same restriction fragment, for example using the method of Sanger et al. (47).
- the double stranded replicative form of DNAs of proven mutants is
- phaseolin protein in transgenic tobacco seeds (Bustos et al., 1990; (49)).
- the advantages of using the minigene instead of phaseolin genomic DNA fragments derive from the absence of intervening sequences. This facilitates the design of gene constructions and permutations of DNA fragments to combine different mutations.
- a 381 bp EcoRI-PstI restriction fragment from clone ⁇ wt i- (Bustos et al., 1990) is subcloned into the phagemid vector pBSKS+ (Stratagene) and the resulting clone is used to produce a U-containing single stranded DNA template.
- Three different synthetic single-stranded oligonucleotide DNA molecules (shown below as oligos I to III) are utilized to mutagenize the wt sequence by the method of Kunkel (46). The individual base substitutions are indicated in boldface.
- oligo II 5' G GTC TTG ATG aaa cct 3' oligo III 5' gcc ATG ATG ATG ATG aaa cct 3' final gly ser ala Met Met Met Met Met lys pro asp 91
- a 2.0 kbp Xbal-BamHI restriction fragment from clone ⁇ wt i- (Bustos et al., 1990) is subcloned into the phagemid vector pBSKS+ (Stratagene) and the resulting clone used to produce a U-containing single-stranded DNA template.
- three synthetic oligonucleotides (oligos IV to VI, shown below) are used to mutagenize the wt sequence using the same method.
- each oligo is designed to mutate two or three closely spaced nucleotides, and all oligos result in at least one new methionine codon.
- the sequences at and around the mutated sites are verified using a sequencing primer that hybridizes near the site. After mutagenesis the Xbal-BamHI fragments are replaced into ⁇ wt i- or into the high-methionine mutants modified at the ILVLV site. A maximum of ten new methionine residues result from the combination of mutations at both sites.
- phaseolin genes are subsequently subcloned into the binary vector pBIN19 and transferred into the genome of tobacco by A. tumefaciens-mediated
- the structure of the high-methionine mutant phaseolin can be investigated by model-building as follows.
- An interactive molecular-graphics computer program (QUANTA, Polygen Corporation) was used to model the replacement of residues 84 to 88 and 261 to 265 by methionine.
- the energyrefinement computer-program XPLOR (Harvard University) was then used to refine the atomic coordinates of the mutant structure to ensure that favourable stereochemistry is achieved, keeping the remainder of the protein as close as possible to the native structure.
- Leu 65 Leu 76, Phe 252, Leu 264, Ile 177, Leu 181.
- Elimination of the loop of structure between beta strands E and F of the C-terminal structural unit may be accomplished by deleting residues numbered 278 to 287 and replacing them with a linker of two glycine residues. This increases the stability of phaseolin to enzymes with
- the selection of sites for mutagenesis may be influenced by the accessibility of the target site to restriction endonucleases.
- the criteria for assessing whether the desired mutation has been achieved will depend on the nature of the mutation attempted, but include;
- the mutation is to substitute methionine for another amino acid
- the presence of one or two met residues could be detected by cyanogen bromide cleavage; the presence of about 10 met residues could be readily assayed by amino acid analysis.
- Retention of three dimensional structure can be assessed in advance by model building, and tested in the protein actually produced by success in expression in vivo, and by various physical analyses such as molecular weight, solubility, and circular dichroism spectral studies. Other suitable methods will be known to those skilled in the art.
- sequence homologies indicate that similar results may be expected with related proteins, such as the homologous protein from pea, and to some extent with legumins as implied by the homology described in reference 16.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
On prévoit des protéines modifiées à conservation des plantes, danbs lesquelles la modification est réalisée dans la structure primaire de la protéine, les structures tertiaire et quaternaire de la protéine étant retenues. Le site des modifications est sélectionné avec référence à la structure à trois dimensions de la protéine, laquelle vient d'être établie par les inventeurs. On revendique également des molécules d'ADN modifiées, des vecteurs, des plantes génovariées, et des parties et des produits de ceux-ci.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPJ6441 | 1989-09-20 | ||
AUPJ644189 | 1989-09-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1991004270A1 true WO1991004270A1 (fr) | 1991-04-04 |
Family
ID=3774203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/AU1990/000430 WO1991004270A1 (fr) | 1989-09-20 | 1990-09-19 | Proteines modifiees a conservation des semences |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO1991004270A1 (fr) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994008018A1 (fr) * | 1992-09-28 | 1994-04-14 | Unilever Plc | Modification de polypeptides |
WO1994010315A3 (fr) * | 1992-10-23 | 1994-09-15 | Pioneer Hi Bred Int | Procede permettant de renforcer la teneur d'une proteine seminale de stockage de semence en un acide amine selectionne |
FR2757538A1 (fr) * | 1996-12-19 | 1998-06-26 | Mini Ricerca Scient Tecnolog | Gene de glutenine a faible masse moleculaire, vecteur d'expression contenant ce gene, microorganisme modifie avec ce vecteur, plants transgeniques contenant ce gene, et proteine codee par ce gene |
WO1998026064A3 (fr) * | 1996-12-09 | 1998-09-03 | Dekalb Genetics Corp | Methodes d'accroissement du contenu nutritionnel de plantes |
US6169232B1 (en) | 1997-07-15 | 2001-01-02 | Dow Agrosciences Llc | Nucleotide sequences of genes encoding sink protein and uses thereof for improving the nutritional quality of feeds |
US7064248B2 (en) | 1990-01-22 | 2006-06-20 | Dekalb Genetics Corp. | Method of preparing fertile transgenic corn plants by microprojectile bombardment |
US7615685B2 (en) | 1990-01-22 | 2009-11-10 | Dekalb Genetics Corporation | Methods of producing human or animal food from stably transformed, fertile maize plants |
US8785130B2 (en) | 2005-07-07 | 2014-07-22 | Bio-Id Diagnostic Inc. | Use of markers including nucleotide sequence based codes to monitor methods of detection and identification of genetic material |
US9150906B2 (en) | 2006-06-28 | 2015-10-06 | Bio-Id Diagnostic Inc. | Determination of variants produced upon replication or transcription of nucleic acid sequences |
EP4139333A4 (fr) * | 2020-04-23 | 2024-10-23 | Pioneer Hi-Bred International, Inc. | Soja à protéine de graine modifiée |
-
1990
- 1990-09-19 WO PCT/AU1990/000430 patent/WO1991004270A1/fr unknown
Non-Patent Citations (5)
Title |
---|
BIOCHEM. PHYSIOL. PFLANZEN, 183, 1988, pp. 211-218, GERHARD SAALBACH et al., "Construction of Storage Protein Genes with Increased Number of Methionine Codons and their Use in Transformation Experiments". * |
FED. PROC. AM. SOC. EXPTL. BIOL, Vol. 46, 6, p. 2023, C.D. DICKINSON et al., "Engineering of Soybean Seed Storage Proteins". * |
NATURE, Volume 339, 29 June 1989, pp. 658-659, DAGMAR RINGE, "The Sheep in Wolf's Clothing". * |
PLANT MOLECULAR BIOLOGY, Vol. 11, 1988, pp. 717-729, L.M. HOFFMAN et al., "A Modified Storage Protein is Synthesized Processed, and Degraded in the Seeds of Transgenic Plants". * |
PROTEIN ENGINEERING, Volume 3, No. 8, 1980, pp. 725-731, CHANSHICK et al., "Improvement of Nutritional Value and Functional Properties of Soybean Glycinin by Protein Engineering". * |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7064248B2 (en) | 1990-01-22 | 2006-06-20 | Dekalb Genetics Corp. | Method of preparing fertile transgenic corn plants by microprojectile bombardment |
US7615685B2 (en) | 1990-01-22 | 2009-11-10 | Dekalb Genetics Corporation | Methods of producing human or animal food from stably transformed, fertile maize plants |
WO1994008018A1 (fr) * | 1992-09-28 | 1994-04-14 | Unilever Plc | Modification de polypeptides |
WO1994010315A3 (fr) * | 1992-10-23 | 1994-09-15 | Pioneer Hi Bred Int | Procede permettant de renforcer la teneur d'une proteine seminale de stockage de semence en un acide amine selectionne |
US7547820B2 (en) | 1993-08-25 | 2009-06-16 | Dekalb Genetics Corporation | Method for altering the nutritional content of plant seed |
US6960709B1 (en) | 1993-08-25 | 2005-11-01 | Dekalb Genetics Corporation | Method for altering the nutritional content of plant seed |
WO1998026064A3 (fr) * | 1996-12-09 | 1998-09-03 | Dekalb Genetics Corp | Methodes d'accroissement du contenu nutritionnel de plantes |
FR2757538A1 (fr) * | 1996-12-19 | 1998-06-26 | Mini Ricerca Scient Tecnolog | Gene de glutenine a faible masse moleculaire, vecteur d'expression contenant ce gene, microorganisme modifie avec ce vecteur, plants transgeniques contenant ce gene, et proteine codee par ce gene |
US6169232B1 (en) | 1997-07-15 | 2001-01-02 | Dow Agrosciences Llc | Nucleotide sequences of genes encoding sink protein and uses thereof for improving the nutritional quality of feeds |
US8785130B2 (en) | 2005-07-07 | 2014-07-22 | Bio-Id Diagnostic Inc. | Use of markers including nucleotide sequence based codes to monitor methods of detection and identification of genetic material |
US9150906B2 (en) | 2006-06-28 | 2015-10-06 | Bio-Id Diagnostic Inc. | Determination of variants produced upon replication or transcription of nucleic acid sequences |
US10036053B2 (en) | 2006-06-28 | 2018-07-31 | Bio-ID Diagnostics Inc. | Determination of variants produced upon replication or transcription of nucleic acid sequences |
EP4139333A4 (fr) * | 2020-04-23 | 2024-10-23 | Pioneer Hi-Bred International, Inc. | Soja à protéine de graine modifiée |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1321157C (fr) | Plantes genetiquement ameliorees, a plus grande resistance aux maladies | |
US5811654A (en) | Plants genetically enhanced for nutritional quality | |
AU728086B2 (en) | Proteins with enhanced levels of essential amino acids | |
Lee et al. | Structure and chromosomal arrangement of leghemoglobin genes in kidney bean suggest divergence in soybean leghemoglobin gene loci following tetraploidization | |
US9029636B2 (en) | Isolated novel nucleic acid and protein molecules from soy and methods of using those molecules to generate transgenic plants with enhanced agronomic traits | |
US5850024A (en) | Reduction of endogenous seed protein levels in plants | |
DE60314902T2 (de) | Fehlpaarungsendonukleasen und verwendungsverfahren | |
CN110462047B (zh) | 晚疫病抗性基因及使用方法 | |
US20120017338A1 (en) | Isolated novel nucleic acid and protein molecules from corn and methods of using those molecules to generate transgenic plant with enhanced agronomic traits | |
CN105646684B (zh) | 一种水稻粒型相关蛋白glw2及其编码基因与应用 | |
Keeler et al. | Expression of de novo high-lysine α-helical coiled-coil proteins may significantly increase the accumulated levels of lysine in mature seeds of transgenic tobacco plants | |
WO1991004270A1 (fr) | Proteines modifiees a conservation des semences | |
US6184437B1 (en) | Lysine rich protein from winged bean | |
CN108395472A (zh) | 一种控制稻类粒长和粒重的基因及其应用 | |
AU3507797A (en) | Aatt promoter element and transcription factor | |
US20130081153A1 (en) | Expression Of Transcription Factor Encoding Genes | |
Dennis et al. | Molecular approaches to crop improvement | |
WO2001009175A2 (fr) | Peptides de synthese | |
CN112458097A (zh) | 金属硫蛋白DaMT2a及其编码基因的应用 | |
US20230151378A1 (en) | Soybean Lines with High Seed Protein and Steady to High Oil Content | |
CN112608930B (zh) | BnaSVP基因在调控油菜花期中的应用、具有不同开花期的油菜突变体材料的制备方法 | |
CN102174523A (zh) | 调控种子大小的基因及其编码的蛋白质和应用 | |
CN101600340A (zh) | 具有改变的油、蛋白或纤维含量的植物的生产 | |
CA2333915A1 (fr) | Diminution dans des plantes des niveaux d'inhibiteurs -de type bowman-birk- de proteases | |
CN109422803A (zh) | 调节植物粒形、千粒重及穗粒数的基因及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU BR CA JP SU US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB IT LU NL SE |
|
NENP | Non-entry into the national phase |
Ref country code: CA |